X
Search Filters
Format Format
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
human necessities (28) 28
devices for introducing media into, or onto, the body (27) 27
devices for producing or ending sleep or stupor (27) 27
devices for transducing body media or for taking media fromthe body (27) 27
hygiene (27) 27
medical or veterinary science (27) 27
oncology (27) 27
index medicus (20) 20
performing operations (20) 20
transporting (20) 20
chemotherapy (15) 15
humans (15) 15
aged (14) 14
female (14) 14
lung cancer, non-small cell (14) 14
male (14) 14
physical or chemical processes or apparatus in general (14) 14
separation (14) 14
general tagging of cross-sectional technologies spanning over several sections of the ipc (13) 13
general tagging of new technological developments (13) 13
lung cancer (13) 13
technical subjects covered by former us classification (13) 13
technical subjects covered by former uspc (13) 13
technical subjects covered by former uspc cross-reference art collections [xracs] and digests (13) 13
middle aged (12) 12
adult (11) 11
analysis (10) 10
cancer (10) 10
care and treatment (10) 10
lung neoplasms - drug therapy (10) 10
epidermal growth factor (9) 9
non-small cell lung cancer (9) 9
patients (9) 9
aged, 80 and over (8) 8
carcinoma, non-small-cell lung - drug therapy (8) 8
lung cancer, small cell (8) 8
non-small cell lung carcinoma (8) 8
respiratory system (8) 8
basic electric elements (7) 7
electricity (7) 7
mutation (7) 7
antineoplastic agents - therapeutic use (6) 6
cisplatin (6) 6
medicine & public health (6) 6
retrospective studies (6) 6
carcinoma, non-small-cell lung - genetics (5) 5
carcinoma, non-small-cell lung - pathology (5) 5
gefitinib (5) 5
lung neoplasms - genetics (5) 5
lung neoplasms - pathology (5) 5
medical research (5) 5
medicine, experimental (5) 5
tyrosine (5) 5
cancer research (4) 4
cancer therapies (4) 4
case report (4) 4
disease (4) 4
disease progression (4) 4
dressing or conditioning of abrading surfaces (4) 4
drug therapy (4) 4
electric solid state devices not otherwise provided for (4) 4
feeding of grinding, polishing, or lapping agents (4) 4
grinding (4) 4
machines, devices, or processes for grinding or polishing (4) 4
polishing (4) 4
prognosis (4) 4
protein kinase inhibitors - therapeutic use (4) 4
research (4) 4
respiratory tract diseases (4) 4
semiconductor devices (4) 4
survival (4) 4
tools for grinding, buffing, or sharpening (4) 4
acquired-resistance (3) 3
acute exacerbation (3) 3
adjuvant chemotherapy (3) 3
antibodies, monoclonal - therapeutic use (3) 3
biopsy (3) 3
carboplatin (3) 3
chemistry (3) 3
computed-tomography (3) 3
diagnosis (3) 3
docetaxel (3) 3
efficacy (3) 3
histology (3) 3
japan (3) 3
measuring (3) 3
medical prognosis (3) 3
metallurgy (3) 3
metastasis (3) 3
neutropenia (3) 3
non-small-cell lung cancer (3) 3
pharmacology & pharmacy (3) 3
physics (3) 3
prospective studies (3) 3
protein-tyrosine kinase (3) 3
receptor, epidermal growth factor - genetics (3) 3
smoking (3) 3
surgical oncology (3) 3
testing (3) 3
therapy (3) 3
more...
Language Language
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Journal of Polymer Science, Part B: Polymer Physics, ISSN 0887-6266, 07/2016, Volume 54, Issue 13, pp. 1237 - 1244
Journal Article
Journal Article
Cancer Science, ISSN 1347-9032, 07/2016, Volume 107, Issue 7, pp. 1001 - 1005
Although third‐generation epidermal growth factor receptor‐tyrosine kinase inhibitors ( EGFR ‐ TKI ) can overcome T790M‐mediated resistance in non‐small‐cell... 
epidermal growth factor receptor‐tyrosine kinase inhibitors | non‐small‐cell lung cancer | rebiopsy | Disease progression | T790M mutation | Non-small-cell lung cancer | Rebiopsy | Epidermal growth factor receptor-tyrosine kinase inhibitors | epidermal growth factor receptor-tyrosine kinase inhibitors | non-small-cell lung cancer | GEFITINIB | NSCLC-PATIENTS | BIOPSY | ACQUIRED-RESISTANCE | EGFR MUTATION | CHEMOTHERAPY | ROCILETINIB | TKI | ONCOLOGY | AZD9291 | Biopsy - methods | Lung Neoplasms - drug therapy | Receptor, Epidermal Growth Factor - genetics | Humans | Middle Aged | Lung Neoplasms - pathology | Male | Antineoplastic Agents - therapeutic use | DNA Mutational Analysis | Treatment Failure | Aged, 80 and over | Adult | Female | Carcinoma, Non-Small-Cell Lung - pathology | Lung Neoplasms - genetics | Lung Neoplasms - enzymology | Carcinoma, Non-Small-Cell Lung - genetics | Japan | Biopsy - statistics & numerical data | Disease Progression | Drug Resistance, Neoplasm - genetics | Neoplasm Metastasis - pathology | Protein Kinase Inhibitors - therapeutic use | Neoplasm Metastasis - diagnosis | Receptor, Epidermal Growth Factor - antagonists & inhibitors | Aged | Carcinoma, Non-Small-Cell Lung - drug therapy | Carcinoma, Non-Small-Cell Lung - enzymology | Clinical Trials as Topic - methods | Mutation | Drug Resistance, Neoplasm - drug effects | Tyrosine | Medical research | Care and treatment | Epidermal growth factor | Analysis | Medicine, Experimental | Phenols | Development and progression | Lung cancer, Non-small cell | Index Medicus | Original
Journal Article
Nutrition and Cancer, ISSN 0163-5581, 07/2019, Volume 71, Issue 5, pp. 767 - 771
This study aimed to explore the tolerability and safety of platinum combination chemotherapy in malnourished patients with advanced non-small cell lung cancer... 
PHASE-III TRIAL | PROGNOSTIC SCORE GPS | NUTRITION & DIETETICS | ONCOLOGY | STATUS ECOG | COOPERATIVE-ONCOLOGY-GROUP | Chemotherapy | Hematology | Toxicity | Platinum | Lung cancer | Non-small cell lung carcinoma | Malnutrition | Survival | Nutritional status
Journal Article
BMC CANCER, ISSN 1471-2407, 08/2019, Volume 19, Issue 1, pp. 762 - 762
Background Acquired immunodeficiency associated with thymoma is a rare disorder. Here we reported a case of acquired immunodeficiency with thymoma, with an... 
Meningitis | Thymoma | ONCOLOGY | Radiotherapy | Good syndrome | Immunodeficiency | Case studies | Complications and side effects | Listeriosis | Development and progression | Diagnosis | Index Medicus
Journal Article
Investigational new drugs, ISSN 0167-6997, 06/2019, pp. 1 - 8
3rd-generation epidermal growth factor receptor-tyrosine kinase inhibitors (EGFR-TKIs), including osimertinib, have reasonable efficacy in non-small-cell lung... 
Tyrosine | Effectiveness | Effusion | Epidermal growth factor receptors | Medical treatment | Lung cancer | Non-small cell lung carcinoma | Cerebrospinal fluid | Kinases | Confidence intervals | Epidermal growth factor | Mutation | Protein-tyrosine kinase | Growth factors
Journal Article
Journal of Thoracic Oncology, ISSN 1556-0864, 10/2018, Volume 13, Issue 10, pp. e207 - e208
Journal Article
BMC Cancer, ISSN 1471-2407, 08/2017, Volume 17, Issue 1, pp. 571 - 571
Journal Article
Respirology, ISSN 1323-7799, 10/2017, Volume 22, Issue 7, pp. 1379 - 1385
Journal Article
Organic Electronics, ISSN 1566-1199, 02/2017, Volume 41, pp. 215 - 220
Dye-doped, submicron fiber waveguides composed of hole- and electron-transport materials, with a mean diameter of 480–660 nm were fabricated and their... 
Hole- and electron-transport materials | Loss coefficient | Electrospinning | Submicron fibers | Waveguide | Organic dyes | PHYSICS, APPLIED | NANOFIBERS | MATERIALS SCIENCE, MULTIDISCIPLINARY | LIGHT-EMITTING-DIODES | COUMARIN LASER-DYES | DEVICES | NANOWIRES | Textile fabrics | Waveguides | Light-emitting diodes | Electron transport
Journal Article
International Journal of Clinical Oncology, ISSN 1341-9625, 8/2015, Volume 20, Issue 4, pp. 668 - 673
Journal Article
Tumor Biology, ISSN 1010-4283, 2/2018, Volume 40, Issue 2, pp. 1010428318760420 - 1010428318760420
Journal Article
Journal of Clinical Oncology, ISSN 0732-183X, 05/2019, Volume 37, Issue 15_suppl, pp. e14732 - e14732
Journal Article
Cancer Chemotherapy and Pharmacology, ISSN 0344-5704, 06/2017, Volume 79, Issue 6, pp. 1229 - 1237
Purpose This study was to determine the incidence and risk factors of febrile neutropenia in chemotherapy-naive Japanese patients treated systemically with... 
Etoposide | Platinum | Lung cancer | Febrile neutropenia | Neutropenia | CARBOPLATIN | 2010 UPDATE | TRIAL | EXTENSIVE-DISEASE | IRINOTECAN/CISPLATIN | ONCOLOGY | RANDOMIZED PHASE-III | GROWTH-FACTORS | CLINICAL-PRACTICE GUIDELINE | NON-HODGKIN-LYMPHOMA | PHARMACOLOGY & PHARMACY | CELL | Lung Neoplasms - drug therapy | Febrile Neutropenia - chemically induced | Humans | Middle Aged | Antineoplastic Combined Chemotherapy Protocols - adverse effects | Male | Radiotherapy - adverse effects | Antineoplastic Agents - administration & dosage | Febrile Neutropenia - prevention & control | Cisplatin - administration & dosage | Incidence | Antineoplastic Agents, Phytogenic - administration & dosage | Aged, 80 and over | Adult | Female | Retrospective Studies | Febrile Neutropenia - epidemiology | Risk Factors | Carboplatin - administration & dosage | Etoposide - administration & dosage | Sex Characteristics | Granulocyte Colony-Stimulating Factor - therapeutic use | Lung Neoplasms - complications | Antineoplastic Combined Chemotherapy Protocols - therapeutic use | Aged | Medical research | Chemotherapy | Cancer patients | Medicine, Experimental | Risk factors | Cancer | Prophylaxis | Radiation therapy | Risk analysis | Multivariate analysis | Patients | Cisplatin | Granulocyte colony-stimulating factor | Quality | Carboplatin | Colony-stimulating factor | Leukocytes (granulocytic) | Index Medicus
Journal Article
19.